11C-Methionine-PET in multiple myeloma: a combined study from two different institutions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Theranostics, 7, 11, S. 2956-2964
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg, Wyoming, NSW
- (wer)
-
Universität Augsburg, Ivyspring International Publisher
- (wann)
-
2017
- Urheber
-
Lapa, Constantin
Garcia-Velloso, Maria J.
Lückerath, Katharina
Samnick, Samuel
Schreder, Martin
Otero, Paula Rodriguez
Schmid, Jan-Stefan
Herrmann, Ken
Knop, Stefan
Buck, Andreas K.
Einsele, Hermann
San-Miguel, Jesus
Kortüm, Klaus Martin
- DOI
-
10.7150/thno.20491
- URN
-
urn:nbn:de:bvb:384-opus4-630215
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lapa, Constantin
- Garcia-Velloso, Maria J.
- Lückerath, Katharina
- Samnick, Samuel
- Schreder, Martin
- Otero, Paula Rodriguez
- Schmid, Jan-Stefan
- Herrmann, Ken
- Knop, Stefan
- Buck, Andreas K.
- Einsele, Hermann
- San-Miguel, Jesus
- Kortüm, Klaus Martin
- Universität Augsburg, Ivyspring International Publisher
Entstanden
- 2017
Ähnliche Objekte (12)
Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma
[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions
Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma
11C-Methionine-PET in multiple myeloma: correlation with clinical parameters and bone marrow involvement
Verschiedene Schreiben
Schriftverkehr mit der Gemeinde Bad Cannstatt
18F-FDG, 11C-methionine, and 68Ga-pentixafor PET/CT in patients with smoldering multiple myeloma: imaging pattern and clinical features
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma
18F-FDG and 11C-methionine PET/CT in newly diagnosed multiple myeloma patients: comparison of volume-based PET biomarkers
Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]
First in man experience of CXCR4-directed endoradiotherapy with Lu-17- and Y-90-labelled Pentixather in multiple myeloma patients [Abstract]
The urgent need for precision medicine in cancer and its microenvironment: the paradigmatic case of multiple myeloma
Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma
[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions
Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma
11C-Methionine-PET in multiple myeloma: correlation with clinical parameters and bone marrow involvement
Verschiedene Schreiben
Schriftverkehr mit der Gemeinde Bad Cannstatt
18F-FDG, 11C-methionine, and 68Ga-pentixafor PET/CT in patients with smoldering multiple myeloma: imaging pattern and clinical features
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma
18F-FDG and 11C-methionine PET/CT in newly diagnosed multiple myeloma patients: comparison of volume-based PET biomarkers
Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]
First in man experience of CXCR4-directed endoradiotherapy with Lu-17- and Y-90-labelled Pentixather in multiple myeloma patients [Abstract]
The urgent need for precision medicine in cancer and its microenvironment: the paradigmatic case of multiple myeloma
Comparison of 11C-choline and 11C-methionine PET/CT in multiple myeloma
[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions
Hexokinase-2 expression in 11C-Methionine–positive, 18F-FDG–negative multiple myeloma
11C-Methionine-PET in multiple myeloma: correlation with clinical parameters and bone marrow involvement
Verschiedene Schreiben
Schriftverkehr mit der Gemeinde Bad Cannstatt
18F-FDG, 11C-methionine, and 68Ga-pentixafor PET/CT in patients with smoldering multiple myeloma: imaging pattern and clinical features
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma
18F-FDG and 11C-methionine PET/CT in newly diagnosed multiple myeloma patients: comparison of volume-based PET biomarkers
Comparison of 11C-Choline and 11C-Methionine-PET/CT in multiple myeloma [Abstract]
First in man experience of CXCR4-directed endoradiotherapy with Lu-17- and Y-90-labelled Pentixather in multiple myeloma patients [Abstract]